Catalyst Wire Dossier Catalyst Wire Dossier

PTM202

· PanTheryx, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PTM202, covering 2013-10-07 to 2018-07-18. Get the full timeline:

Most recent: Clinical Trial Update: PTM202 and Modulation of Host Resistance to Diarrheagenic E. Coli [NA]

See pricing